Whilst previous studies have shown the link between stroke and dementia, they were not able to quantify the percentage increase in risk. The present study was the first meta-analysis to ever look at ...
Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...
The National Institutes of Health Stroke Scale (NIHSS) is accepted as the definitive clinical examination to assess stroke severity. This project examined barriers to implementation and NIHSS use by ...
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By ...
Tenecteplase shows no benefit over standard care for 90-day functional recovery in patients with minor ischemic stroke and disabling deficits.
Young adults account for 10%-14% of patients who have ischemic strokes. The goal of this study was to examine risk factors, diagnostic performance of neuroimaging and tests, and treatment outcomes of ...
The accurate diagnosis of patients presenting to the emergency room with symptoms of stroke is critical; however, rapid assessment is equally important, as the benefit of thrombolytic treatment is ...
In this video, Rebecca Saff, MD, PhD, allergy/immunology fellowship director and assistant physician at Massachusetts General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results